| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $513K | +21.0% | -37.8% |
| Cost of Revenue | $1.3M | -29.7% | +101.9% |
| Gross Profit | -$755K | +45.3% | -483.2% |
| R&D Expense | $600K | +100.0% | -53.8% |
| SG&A Expense | $849K | +26.0% | +7.6% |
| Operating Income | -$9.1M | +9.9% | -55.2% |
| Pre-tax Income | -$11.4M | -5.0% | -69.1% |
| Net Income | -$11.4M | -5.0% | -69.1% |
| EPS (Basic) | -$0.06 | +0.0% | -50.0% |
| EPS (Diluted) | -$0.06 | +0.0% | -50.0% |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.1M | -39.5% | -29.6% |
| Accounts Receivable | $6.1M | +457.5% | +277.1% |
| Inventory | $5.2M | +11.6% | +32.6% |
| Current Assets | $21.1M | +11.5% | +25.4% |
| Total Assets | $41.1M | +4.6% | +19.6% |
| Current Liabilities | $19.7M |
| Line Item | 2026-01-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$19.9M | — | — |
| Capital Expenditures | $1.8M | — | — |
| Investing Cash Flow | -$1.8M | — | — |
| Financing Cash Flow | $22.0M | — | — |
| Free Cash Flow | -$21.7M | — | — |
| +353.6% |
| Total Liabilities | $21.1M | +23.7% | +283.1% |
| Stockholders' Equity | $20.1M | -9.9% | -30.5% |